Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.21M Buy
87,820
+765
+0.9% +$11.7K ﹤0.01% 3400
2014
Q2
$1.45M Buy
87,055
+2,045
+2% +$31.1K ﹤0.01% 3198
2014
Q1
$1.2M Sell
85,010
-490
-0.6% -$7.5K ﹤0.01% 3303
2013
Q4
$1.52M Buy
85,500
+6,890
+9% +$118K ﹤0.01% 3092
2013
Q3
$1.29M Buy
78,610
+1,965
+3% +$29.2K ﹤0.01% 3052
2013
Q2
$1.05M Buy
+76,645
New +$1.08M ﹤0.01% 3284

Other funds holding IX

UBS's IX Position: Q3 2014 in Review

UBS increased its ORIX (IX) stake by 0.88% in Q3 2014, buying an estimated $11.7K and bringing the position to 87,820 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3400.

UBS first reported a position in IX in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.52M in Q4 2013. 102 funds tracked by Wall St. Rank hold IX as of Q3 2014.

  • UBS held 87,820 shares of ORIX worth $1.21M as of Q3 2014.
  • UBS bought 765 ORIX shares in Q3 2014, an estimated $11.7K.
  • ORIX made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3400 holding.
  • UBS first reported a position in ORIX in Q2 2013 and has held it in 6 quarters since.
  • UBS's ORIX position peaked at $1.52M in Q4 2013.
  • 102 funds tracked by Wall St. Rank held ORIX as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.